Reglagene, Inc. — Form D/A
Reglagene, Inc. of TUCSON, AZ, a company, filed a Form D amendment with the SEC on 2023-05-17. The offering totals $3.0M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-05-17
- Form: D/A
- Accession: 0001976902-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.6M
- Remaining: $1.4M
- Minimum investment: $25K
- Investors: 22
- Date of first sale: 2022-07-05
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-451076
Issuer
- Name: Reglagene, Inc.
- CIK: 0001747083
- Entity type: Corporation
- Jurisdiction: ARIZONA
- Incorporated: 2024
- Address: 3320 N. CAMPBELL AVE., SUITE 201, TUCSON, AZ, 85719
- Phone: 5202350365
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Richard Austin | Director | Tucson, AZ |
| Richard Austin | Executive Officer | Tucson, AZ |
| Sharon Ayd | Director | Tucson, AZ |
| Lawrence Kinet | Director | Tucson, AZ |
| Laurence Hurley | Director | Tucson, AZ |
| Ayd Sharon | Director | Tucson, AZ |
| David J Bearss | Director | Sandy, UT |
| Lawrence J Kinet | Director | Oro Valley, AZ |
Other filings by this issuer (5)
More